KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Net Margin (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Net Margin for 10 consecutive years, with 5854.5% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 584677.0% to 5854.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25.24% through Dec 2025, down 1018.0% year-over-year, with the annual reading at 18.75% for FY2025, 369.0% down from the prior year.
  • Net Margin hit 5854.5% in Q4 2025 for Fulgent Genetics, down from 7.86% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 55.84% in Q1 2021 to a low of 5854.5% in Q4 2025.
  • Historically, Net Margin has averaged 312.7% across 5 years, with a median of 12.26% in 2024.
  • Biggest five-year swings in Net Margin: soared 17403bps in 2024 and later crashed -584677bps in 2025.
  • Year by year, Net Margin stood at 41.2% in 2021, then tumbled by -97bps to 1.27% in 2022, then plummeted by -14399bps to 181.76% in 2023, then soared by 96bps to 7.73% in 2024, then crashed by -75680bps to 5854.5% in 2025.
  • Business Quant data shows Net Margin for FLGT at 5854.5% in Q4 2025, 7.86% in Q3 2025, and 23.17% in Q2 2025.